PMID: 3024276Sep 1, 1986Paper

Generation of mediators by limited proteolysis during blood coagulation and fibrinolysis--its pathogenetic role in the adult respiratory distress syndrome (ARDS)

Resuscitation
H NeuhofH R Wolf

Abstract

Products of blood coagulation and fibrinolysis, which are generated by limited proteolysis are able to effect the pulmonary circulation and gas exchange by biochemically mediated actions. Thrombin, fibrin and its degradation products provoke functional and morphological changes in the vessel wall. Fibrinopeptides, fibrin monomers and fibrin (ogen) degradation products induce vasoconstriction and vascular leakage. The vasoconstricting action of fibrin monomers is mediated by thromboxane A2 (TXA2) which is synthetized in the lung tissue itself. Thromboxane synthesis is stimulated by fibrin monomers only in the pulmonary circulation and not in the systemic circulation. Besides their vascular effects, fibrin monomers disturb the function of the surfactant components and increase the surface tension in surfactant monolayers. Proteinase inhibition as a general prophylactic and therapeutic concept with adult respiratory distress syndrome (ARDS) has to include the system of blood coagulation and fibrinolysis predominantly to prevent or stop the generation of products which are able to induce pulmonary vasoconstriction, vascular leakage and impairment of pulmonary gas exchange.

References

May 1, 1978·British Medical Bulletin·S Moncada, J R Vane
Feb 1, 1979·The Journal of Clinical Investigation·P NeedlemanA Raz
Nov 1, 1979·Pathology, Research and Practice·T Saldeen
Jan 1, 1979·Tissue & Cell·J L KadishJ Folkman
Jan 1, 1970·Journal of Clinical Pathology. Supplement (Royal College of Pathologists)·R M Hardaway
Oct 1, 1967·Circulation Research·T BayleyA J Osbahr
Jun 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·S E DahlénB Samuelsson

❮ Previous
Next ❯

Citations

Apr 12, 2003·Critical Care Medicine·Steven Idell
Jan 1, 1991·Acta Anaesthesiologica Scandinavica. Supplementum·A Jolin, L Bjertnaes
Feb 17, 2001·American Journal of Respiratory and Critical Care Medicine·S IdellA L Harabin
May 28, 2011·American Journal of Respiratory Cell and Molecular Biology·Taher NassarAbd Al-Roof Higazi
Aug 25, 2001·American Journal of Respiratory and Critical Care Medicine·S Idell
Jan 15, 2004·American Journal of Respiratory Medicine : Drugs, Devices, and Other Interventions·Steven Idell

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.